Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162M Buy
6,729,967
+579,102
+9% +$15.1M 0.14% 121
2026
Q1
$173M Buy
6,150,865
+660,593
+12% +$17.6M 0.18% 105
2025
Q4
$137M Buy
5,490,272
+627,384
+13% +$15.8M 0.13% 120
2025
Q3
$124M Buy
4,862,888
+276,059
+6% +$6.81M 0.13% 131
2025
Q2
$111M Buy
4,586,829
+164,428
+4% +$3.83M 0.13% 136
2025
Q1
$112M Sell
4,422,401
-708,773
-14% -$18.5M 0.15% 124
2024
Q4
$136M Sell
5,131,174
-614,657
-11% -$16.7M 0.17% 108
2024
Q3
$166M Buy
5,745,831
+37,636
+0.7% +$1.1M 0.21% 94
2024
Q2
$160M Buy
+5,708,195
New +$157M 0.21% 92
2024
Q1
Sell
-6,127,611
Closed -$176M 680
2023
Q4
$176M Buy
6,127,611
+166,366
+3% +$5.03M 0.28% 74
2023
Q3
$198M Buy
5,961,245
+388,575
+7% +$13.7M 0.34% 58
2023
Q2
$204M Sell
5,572,670
-276,691
-5% -$10.8M 0.35% 58
2023
Q1
$239M Sell
5,849,361
-326,767
-5% -$14.1M 0.47% 46
2022
Q4
$316M Sell
6,176,128
-540,402
-8% -$25.9M 0.7% 32
2022
Q3
$294M Sell
6,716,530
-289,168
-4% -$14.1M 0.7% 31
2022
Q2
$367M Buy
7,005,698
+221,321
+3% +$11.3M 0.83% 28
2022
Q1
$351M Buy
6,784,377
+1,554,797
+30% +$80.7M 0.65% 31
2021
Q4
$305M Sell
5,229,580
-3,108
-0.1% -$154K 0.51% 40
2021
Q3
$225M Sell
5,232,688
-4,029
-0.1% -$178K 0.42% 46
2021
Q2
$205M Buy
5,236,717
+609,282
+13% +$23.7M 0.38% 52
2021
Q1
$168M Buy
4,627,435
+301,521
+7% +$10.7M 0.35% 62
2020
Q4
$159M Buy
4,325,914
+362,361
+9% +$13.3M 0.47% 60
2020
Q3
$138M Buy
3,963,553
+130,402
+3% +$4.57M 0.47% 60
2020
Q2
$119M Buy
3,833,151
+367,417
+11% +$12.5M 0.43% 71
2020
Q1
$107M Sell
3,465,734
-150,428
-4% -$5.13M 0.53% 58
2019
Q4
$133M Sell
3,616,162
-1,012,748
-22% -$36.1M 0.54% 66
2019
Q3
$158M Buy
4,628,910
+1,580,416
+52% +$57.5M 0.72% 48
2019
Q2
$125M Buy
3,048,494
+12,319
+0.4% +$489K 0.57% 68
2019
Q1
$122M Sell
3,036,175
-499,734
-14% -$20M 0.58% 60
2018
Q4
$144M Sell
3,535,909
-104,331
-3% -$4.33M 0.79% 48
2018
Q3
$152M Sell
3,640,240
-79,864
-2% -$3.07M 0.68% 53
2018
Q2
$128M Sell
3,720,104
-235,114
-6% -$8.03M 0.63% 52
2018
Q1
$133M Buy
3,955,218
+46,195
+1% +$1.59M 0.69% 49
2017
Q4
$134M Sell
3,909,023
-15,582
-0.4% -$531K 0.73% 48
2017
Q3
$133M Sell
3,924,605
-32,402
-0.8% -$1.04M 0.81% 43
2017
Q2
$126M Buy
3,957,007
+81,885
+2% +$2.58M 0.84% 46
2017
Q1
$126M Sell
3,875,122
-117,652
-3% -$3.71M 0.89% 41
2016
Q4
$123M Sell
3,992,774
-416,312
-9% -$12.7M 0.97% 40
2016
Q3
$142M Sell
4,409,086
-46,703
-1% -$1.56M 1.16% 33
2016
Q2
$149M Sell
4,455,789
-508,910
-10% -$16.2M 1.26% 31
2016
Q1
$140M Buy
4,964,699
+1,129,221
+29% +$32.3M 1.14% 33
2015
Q4
$119M Buy
3,835,478
+48,494
+1% +$1.53M 0.94% 34
2015
Q3
$113M Sell
3,786,984
-185,840
-5% -$5.96M 0.93% 37
2015
Q2
$126M Sell
3,972,824
-45,031
-1% -$1.47M 0.93% 38
2015
Q1
$133M Buy
4,017,855
+131,375
+3% +$4.18M 1.03% 36
2014
Q4
$115M Buy
+3,886,480
New +$111M 0.89% 44
2014
Q1
$133M Buy
+4,017,855
New +$120M 1.03% 36

Other funds holding PFE

Swedbank's PFE Position: Q2 2026 in Review

Swedbank increased its Pfizer (PFE) stake by 9.4% in Q2 2026, buying an estimated $15.1M and bringing the position to 6,729,967 shares worth $162M. The position accounts for 0.14% of the portfolio, ranked #121.

Swedbank first reported a position in PFE in Q1 2014 and has held it in 47 quarters since. The position peaked at $367M in Q2 2022. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Swedbank held 6,729,967 shares of Pfizer worth $162M as of Q2 2026.
  • Swedbank bought 579,102 Pfizer shares in Q2 2026, an estimated $15.1M.
  • Pfizer made up 0.14% of Swedbank's portfolio in Q2 2026, its #121 holding.
  • Swedbank first reported a position in Pfizer in Q1 2014 and has held it in 47 quarters since.
  • Swedbank's Pfizer position peaked at $367M in Q2 2022.
  • 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.